Abbott Labs (ABT) Likely to Benefit as Competitor (QDEL) Reports Strong Numbers - Cowen
Tweet Send to a Friend
Cowen analyst Joshua Jennings reiterated an Outperform rating and $140.00 price target on Abbott Labs (NYSE: ABT) on the belief ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
